Regular Article
Seeking Candidate Mutations That Affect Iron Homeostasis

https://doi.org/10.1006/bcmd.2002.0586Get rights and content

Abstract

ABSTRACT

Hereditary hemochromatosis is characterized by marked variation of expression of the defect: very few homozygotes with the C282Y/C282Y HFE genotype have full-blown clinical disease, a larger number show biochemical stigmata of iron overload, and some seem normal biochemically. The following candidate genes have been examined in detail to determine whether polymorphisms in them may be responsible for this variation: transferrin, transferrin receptor 1, transferrin receptor 2, ferritin-L, ferritin-H, IRP1, IRP2, HFE, β2 microglobulin, mobilferrin/calreticulin, ceruloplasmin, ferroportin, NRAMP1, NRAMP2 (DMT1), haptoglobin, heme oxygenase-1, heme oxygenase-2, hepcidin, USF2, ZIRTL, duodenal cytochrome b ferric reductase (DCYTB), TNFα, keratin 8, and keratin 18. The coding sequence, exon–intron junctions, and promoters of each of these genes was sequenced in DNA from 20 subjects: 5 HFE C282Y/C282Y with clinical disease, 5 HFE C282Y/C282Y with normal/low ferritin levels and no disease, 5 wt/wt with high ferritin and transferrin saturation, and 5 wt/wt normal controls. When coding or promoter polymorphisms were encountered, DNA from large numbers of ethnically defined subjects was examined for these polymorphisms and a relationship between their existence and abnormalities of iron homeostasis was sought. Only in the case of one transferrin mutation did we find a strong relationship between the polymorphism and iron deficiency anemia. The putative genes that affect the expression of HFE mutations remain elusive.

References (76)

  • D. Girelli et al.

    Clinical and pathologic findings in hemochromatosis type 3 due to a novel mutation in transferrin receptor 2 gene

    Gastroenterology

    (2002)
  • A. Roetto et al.

    New mutations inactivating transferrin receptor 2 in hemochromatosis type 3

    Blood

    (2001)
  • O.T. Njajou et al.

    The hemochromatosis N144H mutation of SLC11A3 gene in patients with type 2 diabetes

    Mol. Genet. Metab.

    (2002)
  • A. Roetto et al.

    A valine deletion of ferroportin 1: A common mutation in hemochromatosis type 4?

    Blood

    (2002)
  • V. Devalia et al.

    Autosomal dominant reticuloendothelial iron overload associated with a 3-base pair deletion in the ferroportin 1 gene (SLC11A3)

    Blood

    (2002)
  • D.F. Wallace et al.

    Novel mutation in ferroportin1 is associated with autosomal dominant hemochromatosis

    Blood

    (2002)
  • M. Lioumi et al.

    Isolation and characterization of human and mouse ZIRTL, a member of the IRT1 family of transporters, mapping within the epidermal differentiation complex

    Genomics

    (1999)
  • M. Lioumi et al.

    High-resolution YAC fragmentation map of 1q21

    Genomics

    (1998)
  • G. Papanikolaou et al.

    Linkage to chromosome 1q in Greek families with juvenile hemochromatosis

    Blood Cells Mol. Dis.

    (2001)
  • S.M. Vidal et al.

    Natural resistance to infection with intracellular parasites: isolation of a candidate for Bcg

    Cell

    (1993)
  • P.L. Lee et al.

    The human nramp2 gene: Characterization of the gene structure, alternative splicing, promoter region and polymorphisms

    Blood Cells Mol. Dis.

    (1998)
  • M.E. Conrad et al.

    Iron absorption and transport

    Am. J. Med. Sci.

    (1999)
  • P. Aguilar-Martinez et al.

    A novel mutation in the iron responsive element of ferritin L-subunit gene as a cause for hereditary hyperferritinemia-cataract syndrome

    Blood

    (1996)
  • C. Ferreira et al.

    H ferritin knockout mice: A model of hyperferritinemia in the absence of iron overload

    Blood

    (2001)
  • J. Kato et al.

    A mutation in the iron-responsive element of H ferritin mRNA, causing autosomal dominant iron overload

    Am. J. Hum. Genet.

    (2001)
  • H. Van Vlierberghe et al.

    Haptoglobin phenotype 2-2 overrepresentation in Cys282Tyr hemochromatotic patients

    J. Hepatol.

    (2001)
  • A. Kawashima et al.

    Heme oxygenase-1 deficiency: The first autopsy case

    Hum. Pathol.

    (2002)
  • E.L. Kwak et al.

    Role for NF-kappa B in the regulation of ferritin H by tumor necrosis factor-alpha

    J. Biol. Chem.

    (1995)
  • Y. Tsuji et al.

    Tumor necrosis factor-alpha and interleukin 1-alpha regulate transferrin receptor in human diploid fibroblasts. Relationship to the induction of ferritin heavy chain

    J Biol Chem

    (1991)
  • V.R. Gordeuk et al.

    Decreased concentrations of tumor necrosis factor-a in supernatants of monocytes from homozygotes for hereditary hemochromatosis

    Blood

    (1992)
  • S. Fargion et al.

    Tumor necrosis factor alpha promoter polymorphisms influence the phenotypic expression of hereditary hemochromatosis

    Blood

    (2001)
  • E. Beutler et al.

    Tumor necrosis factor a promoter polymorphisms and liver abnormalities of homozygotes for the c.845 G6A (C282Y) hereditary hemochromatosis mutation

    Blood

    (2002)
  • F.R. Rosendaal

    Venous thrombosis: a multicausal disease

    Lancet

    (1999)
  • E. Beutler et al.

    The effect of alpha-thalassemia on the expression of the beta-thalassemia/HPFH heterozygote in a black family

    Blood

    (1981)
  • A. Roetto et al.

    Juvenile hemochromatosis locus maps to chromosome 1q

    Am. J. Hum. Genet.

    (1999)
  • A. Åsberg et al.

    Persons with screening-detected haemochromatosis: as healthy as the general population?

    Scand. J. Gastroenterol.

    (2002)
  • E. Beutler et al.

    HLA-H and associated proteins in patients with hemochromatosis

    Mol. Med.

    (1997)
  • Cited by (0)

    Communicated by E. Beutler, M.D., 10/14/02

    f1

    Correspondence and reprint requests to: Pauline Lee. E-mail: [email protected].

    View full text